SILO — Silo Pharma, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-09-27.
Performance
Technicals
Others in Healthcare
Measured signals that fired on SILO
| date | signal | measured base rate |
|---|---|---|
| 2026-07-17 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-12-15 | Weisblum Eric Chief Executive Officer | Open-market purchase | 2.5K | 0.42 | 1.1K |
| 2025-12-15 | Weisblum Eric Chief Executive Officer | Open-market purchase | 2.5K | 0.41 | 1.0K |
| 2025-11-21 | Weisblum Eric Chief Executive Officer | Open-market purchase | 1.0K | 0.37 | 370 |
| 2025-11-20 | Weisblum Eric Chief Executive Officer | Open-market purchase | 1.0K | 0.37 | 370 |
| 2025-11-19 | Weisblum Eric Chief Executive Officer | Open-market purchase | 4.5K | 0.41 | 1.8K |
| 2025-11-18 | Weisblum Eric Chief Executive Officer | Open-market purchase | 7.5K | 0.40 | 3.0K |
| 2025-05-27 | Weisblum Eric Chief Executive Officer | Open-market purchase | 10.0K | 0.43 | 4.3K |
| 2024-12-13 | Weisblum Eric CEO and President | Open-market purchase | 2.5K | 0.84 | 2.1K |
| 2024-11-22 | Weisblum Eric CEO and President | Open-market purchase | 2.5K | 0.90 | 2.2K |
| 2024-11-20 | Weisblum Eric CEO and President | Open-market purchase | 2.5K | 0.95 | 2.4K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| AdvisorShares Investments LLC | 238.8K | 664.0K |
| GEODE CAPITAL MANAGEMENT, LLC | 64.8K | 180.0K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22.6K | 62.8K |
| JANE STREET GROUP, LLC | 16.1K | 44.8K |
| CITADEL ADVISORS LLC | 7.7K | 21.4K |
| XTX Topco Ltd | 6.1K | 17.1K |
| TWO SIGMA SECURITIES, LLC | 5.2K | 14.5K |
| VANGUARD FIDUCIARY TRUST CO | 4.7K | 13.1K |
| LPL Financial LLC | 4.5K | 12.5K |
| STATE STREET CORP | 4.5K | 12.5K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Silo Pharma, Inc. (SILO) filed form 8-K · 2026-08-19 · SEC EDGAR
- Silo Pharma, Inc. (SILO) filed form 8-K · 2026-08-17 · SEC EDGAR
Ask the AI about SILO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →